[First isolates of Enterobacter cloacae complex co-producing KPC and NDM in a second level hospital in City of

Olmedo Villarreal1, Ángela Zurita2, Anisabel González3

  • 1Unidad de Enfermedades Infecciosas, Hospital Irma de Lourdes Tzanetatos, Ciudad de Panamá, República de Panamá.

Insights

Two Enterobacter cloacae complex isolates co-producing KPC and NDM carbapenemases were identified in Panama. This dual resistance signifies a new threat, necessitating enhanced surveillance for carbapenemase-producing Enterobacterales.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Carbapenemase-producing Enterobacterales (CPE) are a significant global health threat.
  • KPC and NDM-1 are prevalent carbapenemases, conferring resistance to most antibiotics.
  • Dual carbapenemase production in Enterobacterales represents a novel and critical challenge.

Purpose of the Study:

  • To report the first detection of Enterobacter cloacae complex co-producing KPC and NDM carbapenemases in Panama.
  • To highlight the emergence of multidrug-resistant bacteria in hospital settings.
  • To emphasize the importance of robust epidemiological surveillance.

Main Methods:

  • Isolation and identification of Enterobacter cloacae complex.
  • Detection of carbapenemase genes (KPC and NDM-1) through molecular methods.
  • Clinical surveillance in a second-level hospital.

Main Results:

  • Two isolates of Enterobacter cloacae complex identified as co-producers of KPC and NDM carbapenemases.
  • These isolates exhibit resistance to a broad spectrum of antibiotics.
  • This represents the first documented instance of dual carbapenemase production in this species in Panama.

Conclusions:

  • The emergence of Enterobacterales co-producing KPC and NDM carbapenemases is a new challenge for Panama.
  • Strengthening hospital epidemiological surveillance is crucial for early detection.
  • Timely detection enables the implementation of effective control measures against multidrug-resistant organisms.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
33
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
24
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
129